Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis

Cytokine

Volumn 42, Issue 3, 2008, Pages 345-352

  Zhang, Cai ^a   Zhang, Jianyuan ^b   Yang, Binyan ^a   Wu, Changyou ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

CsA; IL 17; T cell activation; Th17

Indexed keywords

CD3 ANTIBODY; CD69 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD28;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYCLOSPORINE; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS;

EID: 44549083419     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.03.006     Document Type: Article

References (35)

1. Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum 48 (2003) 594-601
2. Lubberts E., Koenders M.I., and van den Berg W.B. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7 (2005) 29-37
3. Jovanovic D.V., Di Battista J.A., Martel-Pelletier J., Jolicoeur F.C., He Y., Zhang M., et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α, by human macrophages. J Immunol 160 (1998) 3513-3521
4. Ziolkowska M., Koc A., Luszczykiewicz G., Ksiezopolska-Pietrzak K., Klimczak E., Chwalinska-Sadowska H., et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164 (2000) 2832-2838
5. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to novel cytokine receptor. Immunity 3 (1995) 811-821
6. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., et al. T cell interleukin-17 induces stromal cells to produce protein inflammatory and hematopoietic cytokines. J Exp Med 183 (1996) 2593-2603
7. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
8. Chabaud M., Durand J.M., Buchs N., Fossiez F., Page G., Frappart L., et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42 (1999) 963-970
9. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103 (1999) 1345-1352
10. Kuligowska M., and Odrowaz-Sypniewska G. Role of interleukin-17 in cartilage and bone destruction in rheumatoid arthritis. Ortop Traumatol Rehabi 6 (2004) 235-241
11. Gaffen S.L. Interleukin-17: a unique inflammatory cytokine with roles in bone biology and arthritis. Arth Res Ther 6 (2004) 240-247
12. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50 (2004) 650-659
13. Borel J.F., Feurer C., Gubler H.V., and Stahelin H. Biological effect of cyclosporin A: a new anti-lymphocytic agent. Agents Actions 6 (1976) 468-475
14. Weischer M., Röcken M., and Berneburg M. Calcineurin inhibitors and rapamycin: cancer protection or promotion?. Exp Dermatol 16 (2007) 385-393
15. Ferretti S., Bonneau O., Dubois G.R., Jones C.E., and Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 170 (2003) 2106-2112
16. Cho M.L., Ju J.H., Kim K.W., Moon Y.M., Lee S.Y., Min S.Y., et al. Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-κB. Immunol Lett 108 (2007) 88-96
17. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
18. Huang J., Ma R., Yang P.Z., and Wu C.Y. Effect of cyclosporin A on the production of IFN-gamma by murine splenocytes. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 22 (2006) 346-349
19. Frassanito M.A., Dammacco R., Fusaro T., Cusmai A., Guerriero S., and Sborgia C. Combined cyclosporin-A/prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells. Clin Exp Immunol 133 (2003) 233-239
20. Grinyó J.M., Cruzado J.M., Millán O., Caldés A., Sabaté I., Gil-Vernet S., et al. Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts. Transplantation 78 (2004) 1400-1403
21. Kobayashi T., Momoi Y., and Iwasaki T. Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-γ, but not TNF-α, in canine mononuclear cells. J Vet Med Sci 69 (2007) 887-892
22. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 423 (2003) 356-361
23. Schulze-Koops H., and Kalden J.R. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 15 (2001) 677-691
24. Ioannou Y., and Isenberg D.A. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 43 (2000) 1431-1442
25. Hirota K., Hashimoto M., Yoshitomi H., Tanaka S., Nomura T., Yamaguchi T., et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204 (2007) 41-47
26. Vermeire K., Heremans H., Vandeputte M., Huang S., Billiau A., and Matthys P. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J Immunol 158 (1997) 5507-5513
27. Raza K., Falciani F., Curnow S.J., Ross E.J., Lee C.Y., Akbar A.N., et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 7 (2005) R784-R795
28. Moseley T.A., Haudenschild D.R., Rose L., and Reddi A.H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14 (2003) 155-174
29. Bettelli E., Oukka M., and Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8 (2007) 345-350
30. Semik-Orzech A., Barczyk A., and Pierzchała W. The role of interleukin 17A in inducing neutrophilic inflammation in the pulmonary tract. Pol Merkur Lekarski 22 (2007) 163-168
31. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
32. Liu X.K., Clements J.L., and Gaffen S.L. Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells. Mol Cells 20 (2005) 339-347
33. Stoddard B.L.Z., and Flick K.E. Calcineurin-immunosuppressor complexes. Curr Opin Struct Biol 6 (1996) 770-775
34. Feske S., Giltnane J., Dolmetsch R., Staudt L.M., and Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2 (2001) 316-324
35. Fierro L., Lund P.E., and Parekh A.B. Comparison of the activation of the Ca2+ release-activated Ca2+ current ICRAC to InsP3 in Jurkat T-lymphocytes, pulmonary artery endothelia and RBL-1 cells. Pflugers Arch 440 (2000) 580-587